Examining barriers to cascade screening for familial hypercholesterolemia in the U.S

•Cascade screening for familial hypercholesterolemia (FH) in the US is hindered by privacy law.•FH does not receive funding commensurate with its contribution to early cardiac disease.•Exceptions to privacy law should be considered to address FH as a public health issue.